Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal estradiol safety study in locally advanced prostate cancer receiving radiotherapy
NL-OMON50312Recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2014
- Countries
- 1
01
Overview
Open-label, single-arm trial of estradiol in prostate cancer (PCa), sponsored by Erasmus MC. Primary endpoint: Incidence of cardiovascular events. Started Sep 2014; status: recruiting.
02
Drugs
estradiol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON50312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50312.